Nektar (NKTR) Down 10.9% Since Last Earnings Report: Can It Rebound?
Nektar (NKTR) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…
Börse:
15,648€
-3,34%
Echtzeit-Aktienkurs Nektar Therapeutics
Bid:
15,545€
Ask:
15,750€
Nachrichten zur Nektar Therapeutics Aktie
Nektar Therapeutics Grinding Its Way Toward Pivotal Data
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nektar Therapeutics Stock Likely To See Higher Levels
Last month we talked about how Nektar Therapeutics stock seems to be a good buying opportunity, and now there have…
Nektar (NKTR) Q4 Earnings and Revenues Top, Pipeline On Track
Nektar (NKTR) reports encouraging fourth-quarter 2020 results. The company plans to initiate a new registrational study on its lead pipeline…
NEKTAR THERAPEUTICS: 10-K Report
10-K...…
Nektar Therapeutics (NKTR) CEO Howard Robin on Q4 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript
NKTR earnings call for the period ending December 31, 2020....…
EARNINGS SUMMARY: Details of Nektar Therapeutics Q4 Earnings Report
WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):-Earnings: -$117.20 million in Q4 vs. -$112.16 million in…
NEKTAR THERAPEUTICS: 8-K Report
CURRENT REPORT...…
Nektar Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results
SAN FRANCISCO , Feb. 25, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results…
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Incyte, Nektar Therapeutics, Immunome and Otonomy
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Incyte, Nektar Therapeutics, Immunome and Otonomy...…
Biotech Stock Roundup: Regulatory Updates From REGN, INCY, & Other Updates
The biotech sector was in focus last week with regulatory and pipeline updates from quite a few companies like Regeneron…
Is a Surprise Coming for Nektar (NKTR) This Earnings Season?
Nektar (NKTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2020 on Thursday, February 25, 2021, After Close of U.S.-Based Financial Markets
SAN FRANCISCO , Feb. 18, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial…
Nektar (NKTR) Teams Up With Merck for Head & Neck Cancer Study
Nektars (NKTR) shares up following a deal with Merck for a combination study of bempegaldesleukin with Keytruda for advanced head…
Thinking about trading options or stock in Nektar Therapeutics, Sleep Number, General Electric, Twilio, or Spirit Airlines?
NEW YORK , Feb. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NKTR,…
NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch
KENILWORTH (NJ) (dpa-AFX) - Todays Daily Dose brings you news about Nektars collaboration with Merck; Pfizer initiating a refractory multiple…
NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch
Todays Daily Dose brings you news about Nektars collaboration with Merck; Pfizer initiating a refractory multiple myeloma study; Processa Pharmas…
Nektar and Merck team up in mid-stage cancer combo study
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer
read more...…
Thinking about trading options or stock in Vir Biotechnology, Verizon, Nektar Therapeutics, Chevron, or Estee Lauder?
NEW YORK , Feb. 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VIR,…
Nektar Collaborates With SFJ Pharma For Bempegaldesleukin In Head And Neck Cancer
KENILWORTH (NJ) (dpa-AFX) - Nektar Therapeutics (NKTR) said that it has reached a financing and co-development collaboration with SFJ Pharmaceuticals…
NEKTAR THERAPEUTICS: 8-K Report
CURRENT REPORT...…
Thinking about trading options or stock in Nektar Therapeutics, Pfizer, AstraZeneca, Vir Biotechnology, or Esperion Therapeutics?
NEW YORK , Feb. 1, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NKTR,…
Nektar Therapeutics (NKTR) Presents At 39th Annual J.P. Morgan Healthcare Conference
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
NEKTAR THERAPEUTICS: 8-K Report
CURRENT REPORT...…
Nektar Therapeutics initiated at hold with $18 price target at Stifel
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
NEKTAR THERAPEUTICS: 8-K Report
CURRENT REPORT...…
Nektar Appoints Dr. Brian Kotzin as Interim Chief Medical Officer and Head of Development
SAN FRANCISCO , Jan. 5, 2021 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today that…
Implied Volatility Surging for Nektar Therapeutics (NKTR) Stock Options
Investors need to pay close attention to Nektar Therapeutics (NKTR) stock based on the movements in the options market lately....…
Nektar to sell Adynovate, Movantik Royalties for $150M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
NEKTAR THERAPEUTICS: 8-K Report
CURRENT REPORT...…
Nektar Therapeutics Announces Agreement with Healthcare Royalty to Sell ADYNOVATE® and MOVANTIK® Royalties for $150 Million
SAN FRANCISCO , Dec. 22, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that it…
Nektar (NKTR) Begins Dosing in NKTR-255 Study for Two Cancers
Nektar (NKTR) doses the first patient in a phase I/II study on NKTR-255 in combination with Erbitux for treating head…
Nektar Therapeutics Announces Presentation of Preclinical Data for NKTR-255, its Novel IL-15 Agonist, at the American Society of Hematology (ASH) 2020 Annual Meeting
SAN FRANCISCO , Dec. 7, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced…
Nektar Therapeutics: A Look At The SITC BEMPEG Data
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nektar Therapeutics immuno-oncology candidates show positive action in early-stage studies
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nektar Therapeutics Presents New Data from Its Immuno-Oncology Pipeline at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
SAN FRANCISCO , Nov. 11, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced…
Nektar (NKTR) Stock Up 3% on Q3 Earnings and Revenue Beat
Nektar (NKTR) reports encouraging third-quarter 2020 results. Enrollment in clinical studies back on track....…
Singapore-based sales productivity platform Nektar raises $2.15 million seed round
Singapore-based Nektar.ai, a productivity platform for sales teams, has raised $2.15 million in seed funding. Founded earlier this year, Nektar…
NEKTAR THERAPEUTICS: 10-Q Report
10-Q...…
Nektar Therapeutics (NKTR) Q3 2020 Earnings Call Transcript
NKTR earnings call for the period ending September 30, 2020....…
Nektar Therapeutics (NKTR) CEO Howard Robin on Q3 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates
Nektar (NKTR) delivered earnings and revenue surprises of 23.75% and 39.34%, respectively, for the quarter ended September 2020. Do the…
Nektar Therapeutics Reports Third Quarter 2020 Financial Results
SAN FRANCISCO , Nov. 5, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today reported financial…
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors for 2020 American College of Rheumatology (ACR) Congress
SAN FRANCISCO , Oct. 29, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today that…
Nektar to Announce Financial Results for the Third Quarter 2020 on Thursday, November 5, 2020, After Close of U.S.-Based Financial Markets
SAN FRANCISCO , Oct. 28, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce…
Nektar Therapeutics Announces Phase 1b Clinical Study to Evaluate Bempegaldesleukin for Treatment of Patients Diagnosed with Mild COVID-19
SAN FRANCISCO , Oct. 27, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that…
34 Kilo Honig pro Volk: Deutschlands Imker nur mit mittelmäßiger Ernte
WACHTBERG (dpa-AFX) - Deutschlands Imker haben dieses Jahr nur eine mittelmäßige Honigernte einholen können. Es sei zu trocken gewesen -…
Nektar (NKTR) Down 12% Since Last Earnings Report: Can It Rebound?
Nektar (NKTR) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…